Katzenstein, H., Chang, K., Krailo, M., Chen, Z., Finegold, M., Rowland, J., . . . Malogolowkin, M. (2009). Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma. A report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group.

Katzenstein, H.M., et al. Amifostine Does Not Prevent Platinum-induced Hearing Loss Associated With the Treatment of Children With Hepatoblastoma. A Report of the Intergroup Hepatoblastoma Study P9645 As a Part of the Children's Oncology Group. 2009.

Katzenstein, H.M., et al. Amifostine Does Not Prevent Platinum-induced Hearing Loss Associated With the Treatment of Children With Hepatoblastoma. A Report of the Intergroup Hepatoblastoma Study P9645 As a Part of the Children's Oncology Group. 2009.